Hemodynamic Complexity of Patent Ductus Arteriosus Management in Preterm Infants - Takeaways - MDSpire

Hemodynamic Complexity of Patent Ductus Arteriosus Management in Preterm Infants

  • By

  • Marjorie M. Makoni

  • June 9, 2026

  • 0 min

Share

  • 1

    The study evaluated four pharmacological regimens for managing patent ductus arteriosus (PDA) in 1356 preterm infants.

  • 2

    The treatment failure rate for PDA was 42.3%, with no significant differences in closure effectiveness among the regimens.

  • 3

    Acetaminophen was associated with increased mortality odds, while indomethacin reduced sepsis but increased bronchopulmonary dysplasia.

  • 4

    Management of PDA should consider physiological nuances and developmental lung stages rather than relying solely on ductal diameter.

  • 5

    The study advocates for individualized, physiologically based management of PDA, integrating various factors affecting treatment outcomes.

Original Source(s)

Related Content